Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Nanosonics Limited ( (AU:NAN) ).
Nanosonics Limited announced a change in the director’s interest, with Gerard Dalbosco acquiring an additional 12,558 ordinary shares, increasing his total to 40,000 shares. This transaction, valued at approximately $51,231.58, reflects a strategic move in the company’s governance, potentially impacting shareholder confidence and market perception.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$4.50 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, focusing on infection prevention solutions. The company is known for its innovative products, particularly in the area of ultrasound probe disinfection, which cater to the needs of healthcare facilities worldwide.
YTD Price Performance: 38.21%
Average Trading Volume: 771,121
Technical Sentiment Signal: Buy
Current Market Cap: A$1.26B
Learn more about NAN stock on TipRanks’ Stock Analysis page.